Outcomes of patients with mitral annular disjunction undergoing mitral valve repair
European Journal of Cardio-Thoracic Surgery · 2025
DOI: 10.1093/ejcts/ezaf029 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2025. Verfasst von Claudio Muneretto und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiac Surgery, Spedali Civili Hospital, University of Brescia, Brescia, Italy. Hauptthemen laut MEDLINE: Mitral Valve, Mitral Valve Prolapse, Mitral Valve Annuloplasty. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES Mitral annular disjunction (MAD) is an abnormal displacement of the posterior mitral leaflet into the left atrial wall, potentially leading to left ventricular dysfunction, malignant ventricular arrhythmias (VA) and sudden cardiac death. This study investigates the outcomes of patients with and without MAD undergoing mitral valve repair for valve prolapse (MVP). METHODS The study retrospectively collected a single-center experience from 2021 to 2023 on 326 consecutive patients undergoing mitral valve repair for MVP. Patients were divided into two groups according to the presence of MAD. After propensity score matching 1:1, two comparable groups of 50 patients were obtained. Primary endpoints included hospital survival and early failure of the repair. Composite secondary endpoint included major adverse cardiac events (MACEs) such as reoperation, residual regurgitation ≥2, severe postoperative left ventricle (LV) dysfunction requiring prolonged (>3 days) inotropic support, cardiac arrhythmias and overall survival. RESULTS After matching, there were no significant differences between the groups in terms of preoperative characteristics. Hospital mortality was 0% in both groups, and there were no significant differences in terms of early reoperation (0%) or residual mitral regurgitation ≥2 or major atrial/VA. Nevertheless, patients with MAD presented a greater need for prolonged inotropic and mechanical circulatory support (IABP/ECMO): No-MAD 0% vs MAD 10% (P = 0.050). However, the composite outcome at midterm follow-up was similar between the groups. CONCLUSIONS Mitral valve repair in patients with MAD was associated with a significantly higher incidence of early LV dysfunction requiring mechanical support. However, no difference was found in terms of survival at follow-up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiac Surgery, Spedali Civili Hospital, University of Brescia, Brescia, Italy.
- Department of Cardiac Surgery, Henri Mondor Hospital, Créteil, France.
- Department of Cardiac Surgery Research, Lankenau Institute for Medical Research, Wynnewood, PA, USA.
- School of Medicine, University of Brescia, Brescia, Italy.
ORCID-Profile: Claudio Muneretto, Massimo Baudo, Francesca Zanin, Fabrizio Rosati, Stefano Benussi, Lorenzo Di Bacco
Zitieren
APA
Muneretto, C., D'Alonzo, M., Baudo, M., Como, L., Segala, A., Zanin, F., Rosati, F., Benussi, S., & Di Bacco, L. (2025). Outcomes of patients with mitral annular disjunction undergoing mitral valve repair. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezaf029
Vancouver
Muneretto C, D'Alonzo M, Baudo M, Como L, Segala A, Zanin F, et al. Outcomes of patients with mitral annular disjunction undergoing mitral valve repair. European Journal of Cardio-Thoracic Surgery. 2025. doi:10.1093/ejcts/ezaf029
BibTeX
@article{Muneretto2025,
author = {Muneretto, Claudio and D'Alonzo, Michele and Baudo, Massimo and Como, Lydia and Segala, Anna and Zanin, Francesca and Rosati, Fabrizio and Benussi, Stefano and Di Bacco, Lorenzo},
title = {Outcomes of patients with mitral annular disjunction undergoing mitral valve repair},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2025},
doi = {10.1093/ejcts/ezaf029}
}
EUVIMED